Hot line on PCI: high bleeding risk and DAPT - part 1

Discussant: F.J. Neumann

Summary

Watch a series of Hot Lines on high bleeding risk and DAPT presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ARC-HBR, MODEL U-SES, Onyx ONE trials.

Presentations available when logged in:

  • The ARC-HBR trade-off model
  • Validation of ARC HBR criteria
  • Impact of HBR on prognosis after PCI
  • Aspirin vs. P2Y12 monotherapy in Onyx-1
  • My analysis of HBR and DAPT studies